| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-04-17 | ABeeC 2.0, LLC | 23andMe Holding Co. | 98,633,827 | 23.9% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | 23andMe Holding Co. | 22,554,104 | 7.2% | EDGAR |
| SC 13D/A | 2024-02-09 | GSK plc | 23andMe Holding Co. | 39,660,487 | 11.2% | EDGAR |
| SC 13G | 2024-01-26 | BlackRock Inc. | 23andMe Holding Co. | 22,467,761 | 7.2% | EDGAR |
| SC 13G | 2023-02-14 | NewView Capital Fund I, L.P. | 23andMe Holding Co. | 19,455,681 | 6.8% | EDGAR |
| SC 13G | 2023-02-13 | BlackRock Inc. | 23andMe Holding Co. | 18,262,355 | 6.4% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | 23andMe Holding Co. | 10,585,342 | 3.7% | EDGAR |
| SC 13G | 2023-02-09 | VANGUARD GROUP INC | 23andMe Holding Co. | 27,187,344 | 9.5% | EDGAR |
| SC 13D/A | 2023-01-20 | GSK PLC | 23andMe Holding Co. | 39,660,487 | 12.2% | EDGAR |
| SC 13G/A | 2022-12-12 | FMR LLC | 23andMe Holding Co. | 15,212,602 | 5.3% | EDGAR |
| SC 13D | 2022-11-04 | GSK PLC | 23andMe Holding Co. | 39,660,487 | 13.2% | EDGAR |
| SC 13G/A | 2022-03-10 | FMR LLC | 23andMe Holding Co. | 24,461,265 | 11.6% | EDGAR |
| SC 13G/A | 2022-02-14 | MARSHALL WACE, LLP | 23andMe Holding Co. | 76,591 | 0.1% | EDGAR |
| SC 13G/A | 2022-02-14 | CITADEL ADVISORS LLC | 23andMe Holding Co. | - | 0.0% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | 23andMe Holding Co. | 24,463,117 | 16.6% | EDGAR |
| SC 13G/A | 2021-12-10 | FMR LLC | 23andMe Holding Co. | 27,141,039 | 18.4% | EDGAR |
| SC 13G | 2021-07-12 | FMR LLC | 23andMe Holding Co. | 31,457,251 | 27.0% | EDGAR |
| SC 13G | 2021-06-30 | SC US (TTGP), LTD. | 23andMe Holding Co. | 3,634,310 | 3.8% | EDGAR |
| SC 13D | 2021-06-25 | ABeeC 2.0, LLC | 23andMe Holding Co. | 98,633,827 | 24.3% | EDGAR |
| SC 13G | 2021-04-26 | CITADEL ADVISORS LLC | VG Acquisition Corp. | - | 4.1% | EDGAR |